The guidance is in response to recent case reports and large case series that have shown a risk of retained gastric contents and cases of pulmonary aspiration during sedation for endoscopic procedures or general anaesthesia in individuals treated with GLP-1RAs or GLP-1/GIPRAs
Lifestyle Factors Complementary strategies for optimal outcomes with GLP-1 therapy [1] [5]
For more detailed instructions, please consult your healthcare provider or pharmacist
People with Absorption Issues : People with Crohns disease or celiac disease may not be able to absorb B12 from food, so injections are a better option
Diabetic ketoacidosis has been reported in insulin-dependent patients who began treatment with a GLP-1 receptor agonist and therefore had their insulin discontinued or their dose rapidly reduced
2 To guide these conversations effectively, providers may benefit from grounding treatment recommendations in a continuum-of-care approach, one that reflects obesity as a chronic condition requiring ongoing, evolving support and acknowledges the potential out-of-pocket costs that can influence follow-through over time